Allianz Asset Management
PGNX

Allianz Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Allianz Asset Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-100,482
Closed -$382K – 2624
2020
Q1 		$382K Sell
100,482
-2,752
-3% -$11.9K ﹤0.01% 2153
2019
Q4 		$525K Sell
103,234
-551
-0.5% -$2.92K ﹤0.01% 2420
2019
Q3 		$525K Sell
103,785
-151,124
-59% -$754K ﹤0.01% 2361
2019
Q2 		$1.57M Buy
254,909
+10,644
+4% +$51.3K ﹤0.01% 1965
2019
Q1 		$1.13M Sell
244,265
-1,390
-0.6% -$6.29K ﹤0.01% 2051
2018
Q4 		$1.03M Sell
245,655
-8,964
-4% -$45.6K ﹤0.01% 2019
2018
Q3 		$1.6M Buy
254,619
+21,635
+9% +$166K ﹤0.01% 2041
2018
Q2 		$1.87M Sell
232,984
-1,330
-0.6% -$10.2K ﹤0.01% 1974
2018
Q1 		$1.75M Buy
234,314
+35,462
+18% +$236K ﹤0.01% 1977
2017
Q4 		$1.18M Sell
198,852
-2,671
-1% -$16.2K ﹤0.01% 2187
2017
Q3 		$1.48M Sell
201,523
-2,679
-1% -$17K ﹤0.01% 2110
2017
Q2 		$1.39M Sell
204,202
-3,635
-2% -$26.8K ﹤0.01% 2113
2017
Q1 		$1.96M Sell
207,837
-3,173
-2% -$31.7K ﹤0.01% 2009
2016
Q4 		$1.82M Sell
211,010
-10,634
-5% -$78.6K ﹤0.01% 2007
2016
Q3 		$1.4M Buy
+221,644
New +$1.34M ﹤0.01% 2110

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Allianz Asset Management's PGNX Position: Q2 2020 in Review

Allianz Asset Management sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 100,482 shares — an estimated $382K sold.

Allianz Asset Management first reported a position in PGNX in Q3 2016 and held it in 15 quarters. The position peaked at $1.96M in Q1 2017. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Allianz Asset Management reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Allianz Asset Management sold 100,482 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $382K.
  • Allianz Asset Management first reported a position in Progenics Pharmaceuticals Inc in Q3 2016 and held it in 15 quarters.
  • Allianz Asset Management's Progenics Pharmaceuticals Inc position peaked at $1.96M in Q1 2017.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Allianz Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.